Liraglutide Injection Market By Type ( Type-a, Type-b ), By Application ( Hypoglycemia, Obesity, Diabetes ), Industry Trends, Estimation & Forecast, 2017 - 2025

  • Published On: Feb, 2019
  • Category: Healthcare
  • Pages: 178
Liraglutide Injection Market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.

Market Overview:

Liraglutide is an analog of human incretin (metabolic hormone) glucagon-like peptide-1 (GLP-1) which is highly efficient when used as a long-acting glucagon-like peptide-1 receptor agonist. This metabolic hormone analog is highly efficient in controlling the complications related to type-2 diabetes as it increases the metabolism of the body by significantly lowering the glucose levels and by binding with the same receptors as done by GLP-1. This medicinal injection is sold under the brand name of Victoza. The laraglutide market is in its nascent stage of development, as the traditional insulin analog is still prevalent among the patients, globally. Moreover, the injection is only approved in very few regions such as the US, Europe and Japan. The European Medicines Agency has recently approved liraglutide, for adults with a body mass index (BMI) of 30. However, apart from its benefits, liraglutide has various side effects as well. Various tests done on animals have revealed that improper or over dosage of liraglutide might result in the occurrence if tumors in thyroid glands. On the other hand, continuously rising number of diabetic patients who are simultaneously dealing with obesity as well, is expected to bring future growth opportunities for the very market in the near future. As per the data revealed by Centers for Disease Control and Prevention (CDC), diabetes has affected more than 20 million people in the U.S. alone and the number is anticipated to reach 30 million by 2030. The report provides detailed qualitative and quantitative analysis of the Global Liraglutide Injection Market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely type and application in each of the major regions.

Liraglutide Injection Market Segmentation

By Type • Type-a • Type-b By Application • Hypoglycemia • Obesity • Diabetes • Others By Geography • North America o U.S. o Canada o Mexico • Europe o U.K. o France o Germany o Italy o Spain o Rest of Europe • Asia-Pacific o China o Japan o India o Korea o Rest of APAC • South America o Brazil o Rest of South America • Rest of the World o Middle East o Africa

CHAPTER 1. INTRODUCTION 1.1. RESEARCH METHODOLOGY 1.1.1. ERC desk research 1.1.2. ERC data synthesis 1.1.3. Data validation and market feedback 1.1.4. ERC data sources CHAPTER 2. LIRAGLUTIDE INJECTION MARKET OVERVIEW 2.1. LIRAGLUTIDE INJECTION MARKET INTRODUCTION 2.2. GLOBAL LIRAGLUTIDE INJECTION MARKET PRODUCTION AND GROWTH RATE, 2017-2025 2.2.1. Global Liraglutide Injection Production (VOLUME) and Growth Rate (%), (2017-2025) 2.3. GLOBAL LIRAGLUTIDE INJECTION MARKET CAPACITY AND GROWTH RATE, 2017-2025 2.3.1. Global Liraglutide Injection Capacity (VOLUME) and Growth Rate (%), (2017-2025) 2.4. GLOBAL LIRAGLUTIDE INJECTION MARKET REVENUE AND GROWTH RATE, 2017-2025 2.4.1. Global Liraglutide Injection Market Revenue (Million USD) and Growth Rate (%), (2017-2025) 2.5. GLOBAL LIRAGLUTIDE INJECTION MARKET CONSUMPTION AND GROWTH RATE, 2017-2025 2.5.1. Global Liraglutide Injection Consumption (VOLUME) and Growth Rate (%), (2017-2025) 2.6. GLOBAL LIRAGLUTIDE INJECTION MARKET PRICE TREND, 2017-2025 2.6.1. Global Liraglutide Injection Market Price Trend and Growth Rate (%), (2017-2025) CHAPTER 3. GLOBAL LIRAGLUTIDE INJECTION MARKET BY TYPE, 2017-2025 3.1. TYPE-A 3.2. TYPE-B 3.3. GLOBAL LIRAGLUTIDE INJECTION MARKET REVENUE BY TYPE, 2017-2025 3.3.1. Global Liraglutide Injection Market Revenue (Million USD) and Share (%) By Type, 2017-2025 3.3.2. Type-a Market Revenue and Growth Rate, 2017-2025 3.3.3. Type-b Market Revenue and Growth Rate, 2017-2025 3.4. GLOBAL LIRAGLUTIDE INJECTION MARKET PRODUCTION BY TYPE, 2017-2025 3.4.1. Global Liraglutide Injection Market Production (Volume) and Share (%) By Type, 2017-2025 3.4.2. Type-a Market Production and Growth Rate, 2017-2025 3.4.3. Type-b Market Production and Growth Rate, 2017-2025 CHAPTER 4. GLOBAL LIRAGLUTIDE INJECTION MARKET BY APPLICATION, 2017-2025 4.1. HYPOGLYCEMIA 4.2. OBESITY 4.3. DIABETES 4.4. GLOBAL LIRAGLUTIDE INJECTION MARKET REVENUE BY APPLICATION, 2017-2025 4.4.1. Global Liraglutide Injection Market Revenue (Million USD) and Share (%) By Application, 2017-2025 4.4.2. Hypoglycemia Market Revenue and Growth Rate, 2017-2025 4.4.3. Obesity Market Revenue and Growth Rate, 2017-2025 4.4.4. Diabetes Market Revenue and Growth Rate, 2017-2025 4.5. GLOBAL LIRAGLUTIDE INJECTION MARKET CONSUMPTION BY APPLICATION, 2017-2025 4.5.1. Global Liraglutide Injection Market Consumption (Volume) and share (%) By Application, 2017-2025 4.5.2. Hypoglycemia Market Consumption and Growth Rate, 2017-2025 4.5.3. Obesity Market Consumption and Growth Rate, 2017-2025 4.5.4. Diabetes Market Consumption and Growth Rate, 2017-2025 Note: Similar information coverage has been provided for other application segment. CHAPTER 5. GLOBAL LIRAGLUTIDE INJECTION MARKET BY REGION, 2017-2025 5.1. NORTH AMERICA 5.1.1. U.S. 5.1.2. Canada 5.1.3. Mexico 5.2. EUROPE 5.2.1. U.K. 5.2.2. France 5.2.3. Germany 5.2.4. Italy 5.2.5. Spain 5.2.6. Rest of Europe 5.3. ASIA PACIFIC 5.3.1. China 5.3.2. Japan 5.3.3. India 5.3.4. Korea 5.3.5. Rest of APAC 5.4. SOUTH AMERICA 5.4.1. Brazil 5.4.2. Rest of South America 5.5. REST OF THE WORLD 5.5.1. Middle East 5.5.2. Africa 5.6. GLOBAL LIRAGLUTIDE INJECTION MARKET REVENUE BY REGION, 2017-2025 5.6.1. Global Liraglutide Injection Market Revenue (Million USD) and Share (%) By Region, 2017-2025 5.6.2. North America Market Revenue and Growth Rate, 2017-2025 5.6.3. Europe Market Revenue and Growth Rate, 2017-2025 5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025 5.6.5. South America Market Revenue and Growth Rate, 2017-2025 5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025 CHAPTER 6. GLOBAL LIRAGLUTIDE INJECTION MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025 6.1. GLOBAL LIRAGLUTIDE INJECTION MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025 6.1.1. Global Liraglutide Injection Market Production (Volume) and Share (%) By Region, 2017-2025 6.1.2. Global Liraglutide Injection Market Consumption (Volume) and Share (%) By Region, 2017-2025 6.1.3. North America Market Production and Consumption, 2017-2025 6.1.4. Europe Market Production and Consumption, 2017-2025 6.1.5. Asia Pacific Market Production and Consumption, 2017-2025 6.1.6. South America Market Production and Consumption, 2017-2025 6.1.7. Rest of the World Market Production and Consumption, 2017-2025 CHAPTER 7. MARKET DETERMINANTS 7.1. MARKET DRIVERS 7.2. MARKET RESTRAINTS 7.3. MARKET OPPORTUNITIES 7.4. MARKET DETERMINANTS RADAR CHART CHAPTER 8. GLOBAL LIRAGLUTIDE INJECTION MARKET COMPETITION BY MANUFACTURERS 8.1. GLOBAL LIRAGLUTIDE INJECTION PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025) 8.1.1. Global Liraglutide Injection Production (VOLUME) and Share (%) by Manufacturers (2017-2025) 8.2. GLOBAL LIRAGLUTIDE INJECTION REVENUE AND SHARE BY MANUFACTURERS (2017-2025) 8.2.1. Global Liraglutide Injection Revenue (Million USD) and Share (%) by Manufacturers (2017-2025) 8.3. LIRAGLUTIDE INJECTION MARKET COMPETITIVE SITUATION AND TRENDS 8.3.1. Liraglutide Injection Market Share (%) of Top 3 Manufacturers 8.3.2. Liraglutide Injection Market Share (%) of Top 5 Manufacturers CHAPTER 9. GLOBAL LIRAGLUTIDE INJECTION MANUFACTURERS ANALYSIS 9.1. COMPANY-A 9.1.1. Business Overview 9.1.2. Company Basic Information 9.1.3. Liraglutide Injection Product Details 9.1.4. Company-A Liraglutide Injection Production, Revenue and Gross Margin 9.2. COMPANY-B 9.2.1. Business Overview 9.2.2. Company Basic Information 9.2.3. Liraglutide Injection Product Details 9.2.4. Company-B Liraglutide Injection Production, Revenue and Gross Margin 9.3. COMPANY-C 9.3.1. Business Overview 9.3.2. Company Basic Information 9.3.3. Liraglutide Injection Product Details 9.3.4. Company-C Liraglutide Injection Production, Revenue and Gross Margin 9.4. COMPANY-D 9.4.1. Business Overview 9.4.2. Company Basic Information 9.4.3. Liraglutide Injection Product Details 9.4.4. Company-D Liraglutide Injection Production, Revenue and Gross Margin 9.5. COMPANY-E 9.5.1. Business Overview 9.5.2. Company Basic Information 9.5.3. Liraglutide Injection Product Details 9.5.4. Company-E Liraglutide Injection Production, Revenue and Gross Margin CHAPTER 10. LIRAGLUTIDE INJECTION MARKET VALUE CHAIN ANALYSIS 10.1. LIRAGLUTIDE INJECTION INDUSTRIAL CHAIN ANALYSIS 10.2. LIRAGLUTIDE INJECTION KEY RAW MATERIALS ANALYSIS 10.2.1. Key Raw Materials 10.2.2. Price Trend of Key Raw Materials 10.2.3. Key Suppliers of Raw Materials 10.3. MARKETING CHANNEL 10.3.1. Direct Marketing 10.3.2. Indirect Marketing 10.3.3. Distributors/Traders 10.4. CONSUMER ANALYSIS 10.4.1. Consumer 1 10.4.2. Consumer 2 10.4.3. Consumer 3 10.4.4. Consumer 4

• Company-A
• Company-B
• Company-C
• Company-D
• Company-E

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS